Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

157
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
157
Relative Risk01:12

Relative Risk

282
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
282
Regression Toward the Mean01:52

Regression Toward the Mean

6.3K
Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when...
6.3K
Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

502
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:  
502
Introduction to Nonparametric Statistics01:28

Introduction to Nonparametric Statistics

831
Nonparametric statistics offer a powerful alternative to traditional parametric methods, useful when assumptions about the population distribution cannot be made. Unlike parametric tests, which require data to follow a specific distribution with well-defined parameters (such as the mean and standard deviation), nonparametric tests do not require such constraints. This makes them particularly valuable when dealing with small sample sizes, skewed data, or ordinal and categorical variables.
One of...
831
Clearance Models: Noncompartmental Models01:17

Clearance Models: Noncompartmental Models

85
Clearance is a pharmacokinetic parameter traditionally defined by compartment models, signifying the rate at which a drug is expelled from the body. However, a noncompartmental model offers an alternative method for assessing clearance, primarily employing empirical data obtained after administering a single drug dose.
The noncompartmental approach capitalizes on extensive sampling data, correlating the volume of distribution to systemic exposure and the administered dosage. This method enables...
85

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Donor Urinary Biomarkers and the Prediction of Deceased Donor Allograft Function.

Journal of the American Society of Nephrology : JASN·2026
Same author

Author Correction: Methodological considerations for evaluating policy impacts on transgender and non-binary youth suicidality.

Nature human behaviour·2026
Same author

Methodological considerations for evaluating policy impacts on transgender and non-binary youth suicidality.

Nature human behaviour·2026
Same author

Affective Neuropsychiatric Symptom Metrics in the National Alzheimer's Coordinating Center Dataset.

medRxiv : the preprint server for health sciences·2025
Same author

Dynamic Risk Prediction of Graft Failure after Deceased Donor Kidney Transplant.

Clinical journal of the American Society of Nephrology : CJASN·2025
Same author

Effects of Prior Diagnosis on Second Opinions and Pathologist Viewing Behaviors: Results from a Randomized Trial in Breast Pathology.

Medical decision making : an international journal of the Society for Medical Decision Making·2025

Related Experiment Video

Updated: Aug 21, 2025

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.2K

Net Reclassification Index Statistics Do Not Help Assess New Risk Models.

Kathleen F Kerr1

  • 1From the Department of Biostatistics, University of Washington School of Public Health, 3980 15th Ave NE, Box 351617, Seattle, WA 98195.

Radiology
|November 15, 2022
PubMed
Summary

Net reclassification index (NRI) statistics are used to compare disease risk models but exhibit statistical issues. These metrics can lead to incorrect inferences and are often misleading for evaluating new risk factors.

More Related Videos

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

178
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.3K

Related Experiment Videos

Last Updated: Aug 21, 2025

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.2K
Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

178
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.3K

Area of Science:

  • Biostatistics
  • Epidemiology
  • Medical Informatics

Background:

  • Evaluating new disease risk factors often involves comparing risk models with and without the novel factor.
  • Net reclassification index (NRI) statistics are commonly used for this model comparison in medical research.
  • These statistics have gained popularity and are frequently published in high-impact medical journals.

Purpose of the Study:

  • To review the statistical properties of Net reclassification index (NRI) statistics.
  • To identify and discuss the limitations and potential problems associated with NRI statistics in risk model evaluation.

Main Methods:

  • Literature review of Net reclassification index (NRI) statistics and their applications.
  • Analysis of statistical behavior and inferential properties of NRI.

Main Results:

  • Net reclassification index (NRI) statistics demonstrate unacceptable statistical behavior.
  • The use of NRI can lead to incorrect statistical inferences regarding risk model performance.
  • Interpretability issues further limit the utility of NRI statistics.

Conclusions:

  • Net reclassification index (NRI) statistics are statistically flawed and should be used with extreme caution.
  • These metrics are often unhelpful and potentially misleading when assessing the value of new risk factors.
  • Alternative methods for risk model comparison may be more appropriate.